▶ 調査レポート

世界の関節再建デバイス市場(~2027):種類別、用途別、地域別

• 英文タイトル:Joint Reconstruction Device Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の関節再建デバイス市場(~2027):種類別、用途別、地域別 / Joint Reconstruction Device Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2305C027資料のイメージです。• レポートコード:MRC2305C027
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、222ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社は、2021年に150.4億ドルであった世界の関節再建デバイス市場規模が、2022年には184.3億ドルに成長し、その後年平均22.71%拡大して2027年には513.8億ドルに達すると予測しています。本調査資料では、関節再建デバイスの世界市場について総合的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別(足首関節置換、指関節置換、肘関節置換、肩関節置換、手首関節置換)分析、用途別(関節固定術、関節鏡検査、関節置換手術、骨切り術、表面再形成手術)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの内容をまとめました。なお、本書内の企業情報には、Aesculap Implant Systems, Inc.、Arthrex, Inc.、B. Braun Melsungen AG、CONMED Corporation、Corin Group PLC、Covidien plc、DePuy Synthes, Inc.、DJO Global Inc.、Integra LifeSciences Corporation、Johnson & Johnson Services, Inc.、Kyocera Corp.などが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の関節再建デバイス市場規模:種類別
- 足首関節置換の市場規模
- 指関節置換の市場規模
- 肘関節置換の市場規模
- 肩関節置換の市場規模
- 手首関節置換の市場規模
・世界の関節再建デバイス市場規模:用途別
- 関節固定術における市場規模
- 関節鏡検査における市場規模
- 関節置換手術における市場規模
- 骨切り術における市場規模
- 表面再形成手術における市場規模
・世界の関節再建デバイス市場規模:地域別
- 南北アメリカの関節再建デバイス市場規模
アメリカの関節再建デバイス市場規模
カナダの関節再建デバイス市場規模
ブラジルの関節再建デバイス市場規模
...
- アジア太平洋の関節再建デバイス市場規模
日本の関節再建デバイス市場規模
中国の関節再建デバイス市場規模
インドの関節再建デバイス市場規模
韓国の関節再建デバイス市場規模
台湾の関節再建デバイス市場規模
...
- ヨーロッパ/中東/アフリカの関節再建デバイス市場規模
イギリスの関節再建デバイス市場規模
ドイツの関節再建デバイス市場規模
フランスの関節再建デバイス市場規模
ロシアの関節再建デバイス市場規模
...
- その他地域の関節再建デバイス市場規模
・競争状況
・企業情報

The Global Joint Reconstruction Device Market size was estimated at USD 15.04 billion in 2021 and expected to reach USD 18.43 billion in 2022, and is projected to grow at a CAGR 22.71% to reach USD 51.38 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Joint Reconstruction Device to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Ankle Replacement, Digits Replacement, Elbow Replacement, Shoulder Replacement, and Wrist Replacement.

Based on Application, the market was studied across Arthrodesis, Arthroscopy, Joint Replacement Surgery, Osteotomy, Resurfacing Surgery, and Small Joint Surgery.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Joint Reconstruction Device market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Joint Reconstruction Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Joint Reconstruction Device Market, including Aesculap Implant Systems, Inc., Arthrex, Inc., B. Braun Melsungen AG, CONMED Corporation, Corin Group PLC, Covidien plc, DePuy Synthes, Inc., DJO Global Inc., Donjoy Inc., Globus Medical, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kyocera Corp., Medtronic PLC, MicroPort Scientific Corp., NuVasive, Inc., OMNI life science, Inc., Smith & Nephew PLC, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Joint Reconstruction Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Joint Reconstruction Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Joint Reconstruction Device Market?
4. What is the competitive strategic window for opportunities in the Global Joint Reconstruction Device Market?
5. What are the technology trends and regulatory frameworks in the Global Joint Reconstruction Device Market?
6. What is the market share of the leading vendors in the Global Joint Reconstruction Device Market?
7. What modes and strategic moves are considered suitable for entering the Global Joint Reconstruction Device Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of orthopedic diseases and associated risk factors
5.1.1.2. Increasing number of outpatient joint replacement procedures
5.1.1.3. Ongoing research and development activity on improving robotically-assisted surgeries and bionic implants
5.1.1.4. Investment by companies in research and development for bigger joint implants
5.1.2. Restraints
5.1.2.1. Decreasing reimbursement options
5.1.2.2. Expensive joint replacement procedures and implants
5.1.3. Opportunities
5.1.3.1. Escalating demand for minimally invasive diagnostic and surgical techniques
5.1.3.2. Increase in geriatric population in Asia Pacific countries
5.1.3.3. Value-based joint replacements are prompting technology innovation in the space
5.1.4. Challenges
5.1.4.1. Biocompatibility issues
5.2. Cumulative Impact of COVID-19

6. Joint Reconstruction Device Market, by Type
6.1. Introduction
6.2. Ankle Replacement
6.3. Digits Replacement
6.4. Elbow Replacement
6.5. Shoulder Replacement
6.6. Wrist Replacement

7. Joint Reconstruction Device Market, by Application
7.1. Introduction
7.2. Arthrodesis
7.3. Arthroscopy
7.4. Joint Replacement Surgery
7.5. Osteotomy
7.6. Resurfacing Surgery
7.7. Small Joint Surgery

8. Americas Joint Reconstruction Device Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Joint Reconstruction Device Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Joint Reconstruction Device Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Aesculap Implant Systems, Inc.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Arthrex, Inc.
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. B. Braun Melsungen AG
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. CONMED Corporation
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Corin Group PLC
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Covidien plc
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. DePuy Synthes, Inc.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. DJO Global Inc.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Donjoy Inc.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Globus Medical
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Integra LifeSciences Corporation
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Johnson & Johnson Services, Inc.
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Kyocera Corp.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Medtronic PLC
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. MicroPort Scientific Corp.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. NuVasive, Inc.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. OMNI life science, Inc.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Smith & Nephew PLC
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Stryker Corporation
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Wright Medical Group N.V.
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Zimmer Biomet Holdings, Inc.
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing